You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pediatric Multiple Sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity and Pediatric Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
    • Philadelphia, Pennsylvania
    • +1 more
    Oct 31, 2022

    Multiple Sclerosis Trial (Endeavor™)

    Not yet recruiting
    • Multiple Sclerosis
    • Action Video Game Treatment
    • New York, New York
      NYU Langone Health - Ambulatory Care Center
    Oct 17, 2022

    Pediatric Multiple Sclerosis Trial in New York (ABMT mobile application)

    Completed
    • Pediatric Multiple Sclerosis
    • ABMT mobile application
    • New York, New York
      NYU Langone Health
    Mar 1, 2022

    Neuropsychology and Imaging in CNS Demyelinating Syndromes.

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +3 more
      • Dallas, Texas
        University Texas Southwestern
      Dec 14, 2022

      Pediatric Multiple Sclerosis Trial in Bakirkoy (Exercise Trainning, Control Group)

      Recruiting
      • Pediatric Multiple Sclerosis
      • Exercise Trainning
      • Control Group
      • Bakırkoy, Istanbul, Turkey
        Istanbul University-Cerrahpasa
      Oct 29, 2021

      Pediatric Multiple Sclerosis Trial in Birmingham, Philadelphia, Toronto (Physical Activity (PA) Intervention, Waitlist

      Recruiting
      • Pediatric Multiple Sclerosis
      • Physical Activity (PA) Intervention
      • Waitlist attention-control
      • Birmingham, Alabama
      • +2 more
      Mar 15, 2022

      Pediatric Onset Multiple Sclerosis (POMS) Trial in Houston (VR active video game intervention, Educational session, Standard

      Terminated
      Has Results
      • Pediatric Onset Multiple Sclerosis (POMS)
      • VR active video game intervention
      • +2 more
      • Houston, Texas
        The University of Texas Health Science Center,Houston
      May 17, 2022

      Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

      Terminated
      • Multiple Sclerosis, Relapsing-Remitting
      • Dimethyl Fumarate
      • +2 more
      • Raleigh, North Carolina
      • +22 more
      Nov 30, 2022

      Respiratory Functions in Pediatric-Onset Multiple Sclerosis

      Recruiting
      • Pediatric-onset Multiple Sclerosis
      • Evaluation of respiratory capacity, respiratory muscle strength and fatigue
      • Istanbul, Bakırköy, Turkey
        Istanbul University-Cerrahpasa
      Nov 5, 2021

      Multiple Sclerosis Trial in Italy, Poland, United States (Ocrelizumab)

      Recruiting
      • Multiple Sclerosis
      • Loma Linda, California
      • +22 more
      Jan 13, 2023

      Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

      Recruiting
      • Multiple Sclerosis (MS)
      • Little Rock, Arkansas
      • +55 more
      Jan 13, 2023

      Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

      Recruiting
      • Relapsing-Remitting Multiple Sclerosis
      • La Jolla, California
      • +66 more
      Jan 27, 2023

      Multiple Sclerosis Trial in Worldwide (Alemtuzumab GZ402673, Glatiramer acetate, Beta-Interferon)

      Active, not recruiting
      Has Results
      • Multiple Sclerosis
      • Alemtuzumab GZ402673
      • +11 more
      • Wien, Austria
      • +20 more
      Jun 16, 2022

      Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

      Recruiting
      • Rheumatoid Arthritis
      • +8 more
      • Moderna mRNA-1273
      • +5 more
      • Los Angeles, California
      • +24 more
      Aug 17, 2022

      Suboptimally Controlled Participants Previously Taking Oral or

      Recruiting
      • Multiple Sclerosis
      • Cladribine Tablets
      • Cullman, Alabama
      • +66 more
      Nov 29, 2022

      Progressive Multiple Sclerosis Trial in Genova, Roma (Osmotin)

      Recruiting
      • Progressive Multiple Sclerosis
      • Osmotin
      • Genova, Italy
      • +1 more
      Jun 30, 2023

      Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

      Recruiting
      Has Results
      • Multiple Sclerosis
      • Interferon beta-1a
      • +3 more
      • Birmingham, Alabama
      • +106 more
      Jan 13, 2023

      Mitochondrial Dysfunction in Primary Progressive Multiple

      Recruiting
      • Multiple Sclerosis
        • Milan, MI, Italy
        • +1 more
        Aug 29, 2023

        Relapsing Multiple Sclerosis, Multiple Sclerosis Trial (Placebo, Pirtobrutinib)

        Not yet recruiting
        • Relapsing Multiple Sclerosis
        • Multiple Sclerosis
        • (no location specified)
        Oct 24, 2023

        Sleep Disorders and Quality of Life in Multiple Sclerosis

        Not yet recruiting
        • Sleep Disorder
          • (no location specified)
          Aug 24, 2023

          Orofacial Pain in Multiple Sclerosis

          Recruiting
          • Multiple Sclerosis
          • Diagnosis of pain
          • Varaždin, Croatia
            Varazdin General Hospital
          Sep 5, 2023

          Multiple Sclerosis Trial in Hamburg (levidex, Control, treatment as usual (TAU))

          Not yet recruiting
          • Multiple Sclerosis
          • levidex
          • +2 more
          • Hamburg, Germany
            GAIA AG
          Oct 19, 2023

          Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive Trial in Cleveland (Cionic

          Recruiting
          • Multiple Sclerosis
          • +2 more
          • Cionic Neural Sleeve NS-100
          • Actigraph accelerometer
          • Cleveland, Ohio
            Cleveland State University
          Jul 25, 2023

          Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

          Not yet recruiting
          • Multiple Sclerosis
          • +2 more
          • KYV-101 anti-CD19 CAR-T cell therapy
          • Standard lymphodepletion regimen
          • Palo Alto, California
            Stanford Multiple Sclerosis Center
          Nov 13, 2023

          Multiple Sclerosis, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

          Not yet recruiting
          • Multiple Sclerosis
          • +2 more
          • Patient Participation Form
          • (no location specified)
          Feb 25, 2023